• About us
• Contact

Advertisement

Product › Details

Omidubicel cell therapy (formerly NiCord®)

	Next higher product group	stem cell therapy_o
	Status	2019-06-19 development p3 existent
	Organisation	Gamida Cell Ltd. (Nasdaq: GMDA)

Record changed: 2023-07-10

Advertisement

More documents for stem cell therapy_o

• [1] Bayer AG. (10/10/23). "Press Release: Bayer Invests 250 million USD in New Cell Therapy Manufacturing Facility in the U.S. [Not intended for US and UK Media]". Berlin....
• [2] BlueRock Therapeutics LP. (8/23/23). "Press Release: BlueRock’s Phase I Study with Bemdaneprocel in Patients with Parkinson’s Disease Meets Primary Endpoint". Wuppertal....
• [3] Bayer AG. (6/8/22). "Press Release: Bayer’s BlueRock Therapeutics Establishes European Site for Cell Therapy Innovation". Berlin....
• [4] Bayer AG. (5/31/22). "Press Release: BlueRock Therapeutics Announces Completion of Enrollment of Phase 1 Trial in Patients with Parkinson’s Disease". Cambridge, MA....
• [5] Promethera Therapeutics S.A.. (6/30/21). "Press Release: Walloon Company Promethera Announces a €20 Million Financing Round". Mont-Saint-Guibert....
• [6] Gamida Cell Ltd.. (5/12/20). "Press Release: Gamida Cell Announces Positive Topline Data from Phase 3 Clinical Study of Omidubicel in Patients with High-Risk Hematologic Malignancies". Boston, MA....
• [7] Promethera Biosciences S.A.. (12/16/19). "Press Release: Promethera Attracts Sony Innovation Fund by IGV and Pegasus Tech Ventures as New Investors in Final Closing of Series D . Total Amount Raise in the Series D Reaches €47.2 Million". Mont-Saint-Guib...
• [8] Lonza Group Ltd.. (6/19/19). "Press Release: Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel". Basel & Boston, MA....
• [9] Promethera Biosciences S.A.. (5/7/19). "Press Release: Promethera Biosciences Completes €39.7 Million ($44.4 Million) Series D Financing". Mont-Saint-Guibert & Tokyo....
• [10] Promethera Biosciences S.A.. (1/2/19). "Press Release: Promethera Biosciences Announces Investment by Itochu Corporation and a Broad Strategic Collaboration to Access the Asian Markets". Mont-Saint-Guibert & Tokyo....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.